Bernd Groner

Georg Speyer Haus — Germany

Medicine · Health Sciences

82h-index22.0kcitations310works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(91), Monoclonal and Polyclonal Antibodies Research(51), Animal Genetics and Reproduction(39), Virus-based gene therapy research(28), Estrogen and related hormone effects(28)

Publications310 total

Correction: Weber et al. Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells. Cancers 2015, 7, 503–537
Cancers·2025Open Access
Supplementary Figure S2 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S1 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S4 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Data from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S3 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S1 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S3 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S4 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Data from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S2 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells
Archives of Toxicology·2018· 71 cited
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Molecular and Cellular Endocrinology·2017· 312 cited
O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
Leukemia·2017· 59 citedOpen Access
Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib
MedChemComm·2016· 14 citedOpen Access
Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular Oncology
PLoS Biology·2016· 3 citedOpen Access
<i>Signal Transduction: Principles, Pathways, and Processes</i>. Edited by Lewis C. Cantley, Tony Hunter, Richard Sever, and Jeremy Thorner. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press. $165.00. xii + 452 p.; ill.; index. ISBN: 978-0-87969-901-7. 2014.
The Quarterly Review of Biology·2016
Chicken lysozyme gene contains several intervening sequences (gene organization/recombinant plasmid/Southern hybridization/cell differentiation)
2016
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Journal of Innate Immunity·2016· 403 citedOpen Access
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
Cancer Research·2015· 64 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Fabrice Gouilleux(14), Nancy E. Hynes(8), Hiroshi Wakao(5), Isabelle Dusanter‐Fourt(5), Manuela Wissler(4), C. Pallard(4), Roland K. Ball(3), Wolfgang Doppler(3), Sylvie Gisselbrecht(3), Vida Vafaizadeh(3), Elisabeth Stöcklin(2), Susanne Saurer(2), Lothar Hennighausen(2), Robert R. Friis(2), Cora‐Ann Schoenenberger(2), Lars-Arne Haldosén(2), Gunnar Norstedt(2), David T. Levy(2), R Weber-Nordt(2), M Schmitt-Ney(2)